Cargando…
Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis
Insulin-like growth factor 1 (IGF-1) plays an important role in bone growth and maintenance, and its decreased levels are associated with bone disorders. This study aimed to evaluate the association of serum IGF-1 levels with osteoporosis, prevalent fractures and fracture risk based on the Fracture...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407172/ https://www.ncbi.nlm.nih.gov/pubmed/36010307 http://dx.doi.org/10.3390/diagnostics12081957 |
_version_ | 1784774299678146560 |
---|---|
author | Saeki, Chisato Oikawa, Tsunekazu Ueda, Kaoru Nakano, Masanori Torisu, Yuichi Saruta, Masayuki Tsubota, Akihito |
author_facet | Saeki, Chisato Oikawa, Tsunekazu Ueda, Kaoru Nakano, Masanori Torisu, Yuichi Saruta, Masayuki Tsubota, Akihito |
author_sort | Saeki, Chisato |
collection | PubMed |
description | Insulin-like growth factor 1 (IGF-1) plays an important role in bone growth and maintenance, and its decreased levels are associated with bone disorders. This study aimed to evaluate the association of serum IGF-1 levels with osteoporosis, prevalent fractures and fracture risk based on the Fracture Risk Assessment Tool (FRAX) in patients with primary biliary cholangitis (PBC). This study included 127 consecutive patients with PBC. Based on the baseline serum IGF-1 levels, the participants were classified into the low (L)-, intermediate (I)- and high (H)-IGF-1 groups. According to the FRAX score, high fracture risk was defined as a 10-year major osteoporotic fracture probability (FRAX-MOF) ≥ 20% or a 10-year hip fracture probability (FRAX-HF) ≥ 3%. The serum IGF-1 levels were positively correlated with bone mineral density, and were negatively correlated with the FRAX-MOF/FRAX-HF. The L-IGF-1 group had the highest prevalence of osteoporosis (58.1%), prevalent fracture (48.4%) and high fracture risk (71.0%). Meanwhile, the H-IGF-1 group had the lowest prevalence of osteoporosis (9.7%), prevalent fracture (12.9%) and high fracture risk (9.7%). The prevalence of these events increased stepwise with decreasing serum IGF-1 levels. The cutoff values of IGF-1 for predicting osteoporosis, prevalent fracture and high fracture risk were 61.5 ng/mL (sensitivity/specificity, 0.545/0.894), 69.5 ng/mL (0.633/0.784) and 61.5 ng/mL (0.512/0.929), respectively. Serum IGF-1 levels were associated with bone disorders and the FRAX-derived fracture risk, and may be a useful indicator for initiating therapeutic intervention to prevent the incidence of fracture in patients with PBC. |
format | Online Article Text |
id | pubmed-9407172 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94071722022-08-26 Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis Saeki, Chisato Oikawa, Tsunekazu Ueda, Kaoru Nakano, Masanori Torisu, Yuichi Saruta, Masayuki Tsubota, Akihito Diagnostics (Basel) Article Insulin-like growth factor 1 (IGF-1) plays an important role in bone growth and maintenance, and its decreased levels are associated with bone disorders. This study aimed to evaluate the association of serum IGF-1 levels with osteoporosis, prevalent fractures and fracture risk based on the Fracture Risk Assessment Tool (FRAX) in patients with primary biliary cholangitis (PBC). This study included 127 consecutive patients with PBC. Based on the baseline serum IGF-1 levels, the participants were classified into the low (L)-, intermediate (I)- and high (H)-IGF-1 groups. According to the FRAX score, high fracture risk was defined as a 10-year major osteoporotic fracture probability (FRAX-MOF) ≥ 20% or a 10-year hip fracture probability (FRAX-HF) ≥ 3%. The serum IGF-1 levels were positively correlated with bone mineral density, and were negatively correlated with the FRAX-MOF/FRAX-HF. The L-IGF-1 group had the highest prevalence of osteoporosis (58.1%), prevalent fracture (48.4%) and high fracture risk (71.0%). Meanwhile, the H-IGF-1 group had the lowest prevalence of osteoporosis (9.7%), prevalent fracture (12.9%) and high fracture risk (9.7%). The prevalence of these events increased stepwise with decreasing serum IGF-1 levels. The cutoff values of IGF-1 for predicting osteoporosis, prevalent fracture and high fracture risk were 61.5 ng/mL (sensitivity/specificity, 0.545/0.894), 69.5 ng/mL (0.633/0.784) and 61.5 ng/mL (0.512/0.929), respectively. Serum IGF-1 levels were associated with bone disorders and the FRAX-derived fracture risk, and may be a useful indicator for initiating therapeutic intervention to prevent the incidence of fracture in patients with PBC. MDPI 2022-08-12 /pmc/articles/PMC9407172/ /pubmed/36010307 http://dx.doi.org/10.3390/diagnostics12081957 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Saeki, Chisato Oikawa, Tsunekazu Ueda, Kaoru Nakano, Masanori Torisu, Yuichi Saruta, Masayuki Tsubota, Akihito Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis |
title | Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis |
title_full | Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis |
title_fullStr | Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis |
title_full_unstemmed | Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis |
title_short | Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis |
title_sort | serum insulin-like growth factor 1 levels, facture risk assessment tool scores and bone disorders in patients with primary biliary cholangitis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407172/ https://www.ncbi.nlm.nih.gov/pubmed/36010307 http://dx.doi.org/10.3390/diagnostics12081957 |
work_keys_str_mv | AT saekichisato seruminsulinlikegrowthfactor1levelsfactureriskassessmenttoolscoresandbonedisordersinpatientswithprimarybiliarycholangitis AT oikawatsunekazu seruminsulinlikegrowthfactor1levelsfactureriskassessmenttoolscoresandbonedisordersinpatientswithprimarybiliarycholangitis AT uedakaoru seruminsulinlikegrowthfactor1levelsfactureriskassessmenttoolscoresandbonedisordersinpatientswithprimarybiliarycholangitis AT nakanomasanori seruminsulinlikegrowthfactor1levelsfactureriskassessmenttoolscoresandbonedisordersinpatientswithprimarybiliarycholangitis AT torisuyuichi seruminsulinlikegrowthfactor1levelsfactureriskassessmenttoolscoresandbonedisordersinpatientswithprimarybiliarycholangitis AT sarutamasayuki seruminsulinlikegrowthfactor1levelsfactureriskassessmenttoolscoresandbonedisordersinpatientswithprimarybiliarycholangitis AT tsubotaakihito seruminsulinlikegrowthfactor1levelsfactureriskassessmenttoolscoresandbonedisordersinpatientswithprimarybiliarycholangitis |